OKYO Pharma Statistics

Total Valuation

OKYO Pharma has a market cap or net worth of $91.69 million. The enterprise value is $90.70 million.

Market Cap	91.69M
Enterprise Value	90.70M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

OKYO Pharma has 37.42 million shares outstanding. The number of shares has increased by 42.96% in one year.

Current Share Class	37.42M
Shares Outstanding	37.42M
Shares Change (YoY)	+42.96%
Shares Change (QoQ)	+30.56%
Owned by Insiders (%)	32.70%
Owned by Institutions (%)	5.54%
Float	25.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.28

Current Ratio	0.28
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.72

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	143.30%
Revenue Per Employee	n/a
Profits Per Employee	-$3.56M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.48M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.63% in the last 52 weeks. The beta is -4.30, so OKYO Pharma's price volatility has been lower than the market average.

Beta (5Y)	-4.30
52-Week Price Change	+107.63%
50-Day Moving Average	1.80
200-Day Moving Average	1.29
Relative Strength Index (RSI)	59.02
Average Volume (20 Days)	214,627

Short Selling Information

The latest short interest is 192,209, so 0.51% of the outstanding shares have been sold short.

Short Interest	192,209
Short Previous Month	175,726
Short % of Shares Out	0.51%
Short % of Float	0.76%
Short Ratio (days to cover)	0.80

Income Statement

Revenue	n/a
Gross Profit	-4.49M
Operating Income	-10.35M
Pretax Income	-13.28M
Net Income	-10.69M
EBITDA	-10.35M
EBIT	-10.35M
Earnings Per Share (EPS)	-$0.32

Full Income Statement

Balance Sheet

The company has $987,199 in cash and $1,808 in debt, giving a net cash position of $985,391 or $0.03 per share.

Cash & Cash Equivalents	987,199
Total Debt	1,808
Net Cash	985,391
Net Cash Per Share	$0.03
Equity (Book Value)	-7.23M
Book Value Per Share	-0.21
Working Capital	-7.23M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.94M
Capital Expenditures	n/a
Free Cash Flow	-2.94M
FCF Per Share	-$0.08

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OKYO Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.96%
Shareholder Yield	-42.96%
Earnings Yield	-11.66%
FCF Yield	-3.21%

Analyst Forecast

The average price target for OKYO Pharma is $7.00, which is 185.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	185.71%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 22, 2023. It was a reverse split with a ratio of 0.0153846:1.

Last Split Date	May 22, 2023
Split Type	Reverse
Split Ratio	0.0153846:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1